Executive Director, TA Oncology Strategy and Execution Lead

Join a Legacy of Innovation 125 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.   

Job Summary:

The TA Oncology Strategy and Execution Lead is a pivotal leadership role responsible for driving the strategic and operational effectiveness of this newly formed TA Oncology organization. This position will report to the Global Head of Late-Stage Oncology Development. This individual will play a central role in supporting the Global Head of Late-Stage Oncology Development in the formation and management of the newly created TA Oncology Leadership team and in driving strategy, management and facilitation of key programs and initiatives, ensuring alignment of strategic priorities, resources allocation and capability elevation. As an integral member of the Leadership team, the position will closely collaborate with key stakeholders and leaders across the R&D organization to achieve desired business results, optimize ways of working and enhance overall functional excellence across the newly formed TA Oncology organization The incumbent will be expected to independently lead cross functional initiatives intended to build capabilities, improve processes, and foster collaboration and connectivity to enhance the operational efficiency of the TA Oncology organization. Such initiatives may be conducted or coordinated in partnership with members of the RD Operations organization or with the functional excellence teams of functions within the TA Oncology organization. The individual may also support, or lead initiatives intended to expand the Daiichi Sankyo global development footprint or to promote globalization. The incumbent will also have direct accountability for administrative deliverables and will be responsible for coordinating resource management of the TA Oncology organization with chiefs of staff of functions within the organization. In the addition, the individual will help plan the transition of asset programs from early to late-stage development in coordination with the Early-Stage Oncology Development organization and other functions within global R&D. The position will also be expected to provide guidance and mentorship to the chiefs of staff of functions within the TA Oncology organization as well as to build processes intended to optimize the communication flow within the functions of the organization.

Responsibilities:

• Strategic integration functional excellence: Build a thorough understanding of all core business functions within the TA Oncology organization and apply that knowledge to effectively manage strategic and tactical initiatives under the guidance of the TA Leadership team and in partnership with members of the RD Operations organization or with the functional excellence teams of functions within the TA Oncology organization. Serve as a trusted partner to the Head of Late-Stage Oncology Development, providing insights and recommendations on functional priorities and challenges, and support the Head in leadership and execution of programs and initiatives that will help shape and drive late-stage strategy and operational delivery.

• Proactively identify issues that could impact the successful execution of TA Oncology business objectives; escalation of such issues to the Global Head of Late-Stage Oncology Development while proactively formulating plans to address the concerns and mitigate associated risks; Accountability for day-to-day Late-Stage Oncology business operations as decided by the Global Head of Late-Stage Oncology Development.

• Program Asset Transition Leadership: Coordinate resource management for the TA Oncology organization with chiefs of staff of functions within the organization. In the addition, proactively plan for the transition of asset programs from early to late-stage development in coordination with the Early-Stage Oncology Development organization and other functions within global RD, address potential challenges and optimize transition strategies

• Executive Advisory Communications: provide strategic insights and deliver concise updates on project statuses and next steps to prepare the Head of Late Stage Oncology Development for upcoming discussions, commitments, and meetings; Prepare presentation documents, speaker notes and memos for meetings, conferences and other venues as needed; Act as representative for the Head of Late Stage Oncology Development in appropriate meetings to gather information, provide input and facilitate efficient decision making

• In conjunction with finance and Project Management support the Head of Oncology Late-Stage Development in management of budget, capacity, resources and preparation of associated reports

• Prepare communications on behalf of the Global Head of Late-Stage Oncology Development for stakeholders of all levels both internally and externally

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education:

• Master's Degree Advanced degree in a scientific discipline required and

• PharmD preferred or

• PhD preferred or

• MD preferred

Experience:

• 10 or More Years of prior experience in project management or similar functional experience within the biotech/pharmaceutical industry required and

• Demonstrated understanding of the clinical research process and oncology drug development required and

• Demonstrated track-record of complex decision making, communication and collaboration skills with proven cross-functional and multi-level relationship building and stakeholder management skills Experience with workforce planning and managing operating budgets with varying degrees of complexity Strategic and analytical abilities, diplomacy, negotiation and excellent oral and written communications skills. Ability to influence internal and external stakeholder groups Experience operating in a matrix environment required

Travel:

• Ability to travel up to 10%

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.